Detalhe da pesquisa
1.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940409
2.
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases.
Brain
; 146(2): 421-437, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083979
3.
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710320
4.
Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review.
J Stroke Cerebrovasc Dis
; 31(3): 106292, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026496
5.
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4.
Int J Mol Sci
; 23(21)2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362248
6.
Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients.
Ann Neurol
; 83(5): 1032-1036, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29665046
7.
Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies".
Acta Neuropathol
; 147(1): 30, 2024 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308717
8.
Reply to "Interpretation of Longitudinal Changes of the Inner Nuclear Layer in MS".
Ann Neurol
; 92(1): 156, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403744
9.
Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome.
Brain
; 144(5): e44, 2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822000
10.
Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
Int J Mol Sci
; 16(8): 17565-88, 2015 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26263977
11.
Neurofilaments as biomarkers in neurological disorders - towards clinical application.
Nat Rev Neurol
; 20(5): 269-287, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609644
12.
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
Ann Clin Transl Neurol
; 11(2): 477-485, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111972
13.
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis.
Mult Scler Relat Disord
; 81: 105139, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000130
14.
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis.
Cell Rep Med
; 5(4): 101490, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574736
15.
An autoantibody signature predictive for multiple sclerosis.
Nat Med
; 30(5): 1300-1308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641750
16.
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study.
Lancet Neurol
; 22(9): 826-833, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524100
17.
Remyelination protects neurons from DLK-mediated neurodegeneration.
bioRxiv
; 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37873342
18.
Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878713
19.
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
JAMA Neurol
; 80(3): 287-297, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745446
20.
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis.
J Neurol
; 270(7): 3315-3328, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184659